Antibody epitopes on G protein-coupled receptors mapped with genetically encoded photoactivatable cross-linkers

Biochemistry

Volumn 53, Issue 8, 2014, Pages 1302-1310

  Ray Saha, Sarmistha ^a   Huber, Thomas ^a   Sakmar, Thomas P ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTORS; CXC CHEMOKINE RECEPTOR 4; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR LOOP 2; G PROTEIN COUPLED RECEPTORS; HUMAN IMMUNODEFICIENCY VIRUS-1; MONOCLONAL ANTIBODIES (MABS); UNNATURAL AMINO ACIDS;

AMINO ACIDS; MONOCLONAL ANTIBODIES; PROTEINS;

EPITOPES;

4 AZIDO LEVO PHENYLALANINE; ANTIBODY; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; EPITOPE; G PROTEIN COUPLED RECEPTOR; MARAVIROC; MONOCLONAL ANTIBODY; PHENYLALANINE; PRO 140; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; CROSS LINKING; CRYSTAL STRUCTURE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; PHOTOACTIVATION; PRIORITY JOURNAL; VIRUS ENTRY; WESTERN BLOTTING;

ANTIBODIES, MONOCLONAL; AZIDES; EPITOPE MAPPING; HUMANS; MODELS, MOLECULAR; MUTATION; PHENYLALANINE; PHOTOCHEMICAL PROCESSES; PROTEIN CONFORMATION; PROTEIN ENGINEERING; RECEPTORS, CCR5; RECEPTORS, CXCR4; RECEPTORS, G-PROTEIN-COUPLED;

EID: 84896750534     PISSN: 00062960     EISSN: 15204995     Source Type: Journal    
DOI: 10.1021/bi401289p     Document Type: Article

References (67)

1. Herr, D. R. (2012) Potential use of G protein-coupled receptor-blocking monoclonal antibodies as therapeutic agents for cancers Int. Rev. Cell Mol. Biol. 45-81
2. Nelson, A. L., Dhimolea, E., and Reichert, J. M. (2010) Development trends for human monoclonal antibody therapeutics Nat. Rev. Drug Discovery 9, 767-774
3. Schall, T. J. and Proudfoot, A. E. I. (2011) Overcoming hurdles in developing successful drugs targeting chemokine receptors Nat. Rev. Immunol. 11, 355-363
4. Olson, W. C. and Jacobson, J. M. (2009) CCR5 monoclonal antibodies for HIV-1 therapy Curr. Opin. HIV AIDS 4, 104-111
5. Strizki, J. M., Turner, J. D., Collman, R. G., Hoxie, J., and GonzalezScarano, F. (1997) A monoclonal antibody (12G5) directed against CXCR-4 inhibits infection with the dual-tropic human immunodeficiency virus type 1 isolate HIV-1(89.6) but not the T-tropic isolate HIV-1(HxB) J. Virol. 71, 5678-5683
6. McKnight, A., Wilkinson, D., Simmons, G., Talbot, S., Picard, L., Ahuja, M., Marsh, M., Hoxie, J. A., and Clapham, P. R. (1997) Inhibition of human immunodeficiency virus fusion by a monoclonal antibody to a coreceptor (CXCR4) is both cell type and virus strain dependent J. Virol. 71, 1692-1696
7. Ji, C., Brandt, M., Dioszegi, M., Jekle, A., Schwoerer, S., Challand, S., Zhang, J., Chen, Y., Zautke, L., Achhammer, G., Baehner, M., Kroetz, S., Heilek-Snyder, G., Schumacher, R., Cammack, N., and Sankuratri, S. (2007) Novel CCR5 monoclonal antibodies with potent and broad-spectrum anti-HIV activities Antiviral Res. 74, 125-137
8. Endres, M. J., Clapham, P. R., Marsh, M., Ahuja, M., Turner, J. D., McKnight, A., Thomas, J. F., StoebenauHaggarty, B., Choe, S., Vance, P. J., Wells, T. N. C., Power, C. A., Sutterwala, S. S., Doms, R. W., Landau, N. R., and Hoxie, J. A. (1996) CD4-independent infection by HIV-2 is mediated by Fusin/CXCR4 Cell 87, 745-756
9. Wu, L. J., LaRosa, G., Kassam, N., Gordon, C. J., Heath, H., Ruffing, N., Chen, H., Humblias, J., Samson, M., Parmentier, M., Moore, J. P., and Mackay, C. R. (1997) Interaction of chemokine receptor CCR5 with its ligands: Multiple domains for HIV-1 gp120 binding and a single domain for chemokine binding J. Exp. Med. 186, 1373-1381
10. Olson, W. C., Rabut, G. E. E., Nagashima, K. A., Tran, D. N. H., Anselma, D. J., Monard, S. P., Segal, J. P., Thompson, D. A. D., Kajumo, F., Guo, Y., Moore, J. P., Maddon, P. J., and Dragic, T. (1999) Differential inhibition of human immunodeficiency virus type 1 fusion, gp120 binding, and CC-chemokine activity by monoclonal antibodies to CCR5 J. Virol. 73, 4145-4155
11. Carnec, X., Quan, L., Olson, W. C., Hazan, U., and Dragic, T. (2005) Anti-CXCR4 monoclonal antibodies recognizing overlapping epitopes differ significantly in their ability to inhibit entry of human immunodeficiency virus type 1 J. Virol. 79, 1930-1933
12. Khurana, S., Kennedy, M., King, L. R., and Golding, H. (2005) Identification of a linear peptide recognized by monoclonal antibody 2D7 capable of generating CCR5-specific antibodies with human immunodeficiency virus-neutralizing activity J. Virol. 79, 6791-6800
13. Murga, J. D., Franti, M., Pevear, D. C., Maddon, P. J., and Olson, W. C. (2006) Potent antiviral synergy between monoclonal antibody and small-molecule CCR5 inhibitors of human immunodeficiency virus type 1 Antimicrob. Agents Chemother. 50, 3289-3296
14. Trkola, A., Ketas, T. J., Nagashima, K. A., Zhao, L., Cilliers, T., Morris, L., Moore, J. P., Maddon, P. J., and Olson, W. C. (2001) Potent, broad-spectrum inhibition of human immunodeficiency virus type 1 by the CCR5 monoclonal antibody PRO 140 J. Virol. 75, 579-588
15. Baribaud, F., Edwards, T. G., Sharron, M., Brelot, T., Heveker, N., Price, K., Mortari, F., Alizon, M., Tsang, M., and Doms, R. W. (2001) Antigenically distinct conformations of CXCR4 J. Virol. 75, 8957-8967
16. Brelot, A., Heveker, N., Montes, M., and Alizon, M. (2000) Identification of residues of CXCR4 critical for human immunodeficiency virus coreceptor and chemokine receptor activities J. Biol. Chem. 275, 23736-23744
17. Brelot, A., Heveker, N., Adema, K., Hosie, M. J., Willett, B., and Alizon, M. (1999) Effect of mutations in the second extracellular loop of CXCR4 on its utilization by human and feline immunodeficiency viruses J. Virol. 73, 2576-2586
18. Timmerman, P., Puijk, W. C., and Meloen, R. H. (2009) Functional reconstitution of structurally complex epitopes using CLIPS™ technology Biopolymers 92, 351-351
19. Paes, C., Ingalls, J., Kampani, K., Sulli, C., Kakkar, E., Murray, M., Kotelnikov, V., Greene, T. A., Rucker, J. B., and Doranz, B. J. (2009) Atomic-Level Mapping of Antibody Epitopes on a GPCR J. Am. Chem. Soc. 131, 6952-6954
20. Zhang, J., Rao, E., Dioszegi, M., Kondru, R., DeRosier, A., Chan, E., Schwoerer, S., Cammack, N., Brandt, M., Sankuratri, S., and Ji, C. (2007) The second extracellular loop of CCR5 contains the dominant epitopes for highly potent anti-human immunodeficiency virus monoclonal antibodies Antimicrob. Agents Chemother. 51, 1386-1397
21. Klasse, P. J. (2012) The molecular basis of HIV entry Cell. Microbiol. 14, 1183-1192
22. Wu, Y. and Yoder, A. (2009) Chemokine coreceptor signaling in HIV-1 infection and pathogenesis PLoS Pathog. 5, e1000520
23. Didigu, C. A. and Doms, R. W. (2012) Novel Approaches to Inhibit HIV Entry Viruses 4, 309-324
24. Ipsen, H., Henmar, H., Bolwig, C., Duffort, O., Barber, D., Polo, F., and Larsen, J. (2004) Mapping of Der p 2 antibody binding epitopes by site directed mutagenesis J. Allergy Clin. Immunol. 113, S144
25. Rockberg, J., Lofblom, J., Hjelm, B., Uhlen, M., and Stahl, S. (2008) Epitope mapping of antibodies using bacterial surface display Nat. Methods 5, 1039-1045
26. Sidhu, S. S. (2000) Phage display in pharmaceutical biotechnology Curr. Opin. Biotechnol. 11, 610-616
27. Wyatt, R., Kwong, P. D., Desjardins, E., Sweet, R. W., Robinson, J., Hendrickson, W. A., and Sodroski, J. G. (1998) The antigenic structure of the HIV gp120 envelope glycoprotein Nature 393, 705-711
28. Wu, B. L., Chien, E. Y. T., Mol, C. D., Fenalti, G., Liu, W., Katritch, V., Abagyan, R., Brooun, A., Wells, P., Bi, F. C., Hamel, D. J., Kuhn, P., Handel, T. M., Cherezov, V., and Stevens, R. C. (2010) Structures of the CXCR4 Chemokine GPCR with Small-Molecule and Cyclic Peptide Antagonists Science 330, 1066-1071
29. Tan, Q., Zhu, Y., Li, J., Chen, Z., Han, G. W., Kufareva, I., Li, T., Ma, L., Fenalti, G., Li, J., Zhang, W., Xie, X., Yang, H., Jiang, H., Cherezov, V., Liu, H., Stevens, R. C., Zhao, Q., and Wu, B. (2013) Structure of the CCR5 Chemokine Receptor-HIV Entry Inhibitor Maraviroc Complex Science 341, 1387-1390
30. Wang, Q., Parrish, A. R., and Wang, L. (2009) Expanding the Genetic Code for Biological Studies Chem. Biol. 16, 323-336
31. Daggett, K. A. and Sakmar, T. P. (2011) Site-specific in vitro and in vivo incorporation of molecular probes to study G-protein-coupled receptors Curr. Opin. Chem. Biol. 15, 392-398
32. Chin, J. W., Martin, A. B., King, D. S., Wang, L., and Schultz, P. G. (2002) Addition of a photo-cross-linking amino acid to the genetic code of Escherichia coli Proc. Natl. Acad. Sci. U.S.A. 99, 11020-11024
33. Chin, J. W., Santoro, S. W., Martin, A. B., King, D. S., Wang, L., and Schultz, P. G. (2002) Addition of p-azido- l -phenylaianine to the genetic code of Escherichia coli J. Am. Chem. Soc. 124, 9026-9027
34. Chin, J. W., Cropp, T. A., Anderson, J. C., Mukherji, M., Zhang, Z. W., and Schultz, P. G. (2003) An expanded eukaryotic genetic code Science 301, 964-967
35. Ye, S., Kohrer, C., Huber, T., Kazmi, M., Sachdev, P., Yan, E. C. Y., Bhagat, A., RajBhandary, U. L., and Sakmar, T. P. (2008) Site-specific incorporation of keto amino acids into functional G protein-coupled receptors using unnatural amino acid mutagenesis J. Biol. Chem. 283, 1525-1533
36. Ye, S. X., Huber, T., Vogel, R., and Sakmar, T. P. (2009) FTIR analysis of GPCR activation using azido probes Nat. Chem. Biol. 5, 397-399
37. Ye, S. X., Zaitseva, E., Caltabiano, G., Schertler, G. F. X., Sakmar, T. P., Deupi, X., and Vogel, R. (2010) Tracking G-protein-coupled receptor activation using genetically encoded infrared probes Nature 464, 1386-1390
38. Sletten, E. M. and Bertozzi, C. R. (2009) Bioorthogonal Chemistry: Fishing for Selectivity in a Sea of Functionality Angew. Chem., Int. Ed. 48, 6974-6998
39. Naganathan, S., Ye, S., Sakmar, T. P., and Huber, T. (2013) Site-Specific Epitope Tagging of G Protein-Coupled Receptors by Bioorthogonal Modification of a Genetically Encoded Unnatural Amino Acid Biochemistry 52, 1028-1036
40. Huber, T., Naganathan, S., Tian, H., Ye, S., and Sakmar, T. P. (2013) Unnatural Amino Acid Mutagenesis of GPCRs Using Amber Codon Suppression and Bioorthogonal Labeling Methods Enzymol. 520, 281-305
41. Grunbeck, A., Huber, T., Abrol, R., Trzaskowski, B., Goddard, W. A., III, and Sakmar, T. P. (2012) Genetically Encoded Photo-cross-linkers Map the Binding Site of an Allosteric Drug on a G Protein-Coupled Receptor ACS Chem. Biol. 7, 967-972
42. Grunbeck, A., Huber, T., Sachdev, P., and Sakmar, T. P. (2011) Mapping the Ligand-Binding Site on a G Protein-Coupled Receptor (GPCR) Using Genetically Encoded Photocross-linkers Biochemistry 50, 3411-3413
43. Grunbeck, A., Huber, T., and Sakmar, T. P. (2013) Mapping a Ligand Binding Site Using Genetically Encoded Photoactivatable Cross-linkers Methods Enzymol. 520, 307-322
44. Sato, S., Mimasu, S., Sato, A., Hino, N., Sakamoto, K., Umehara, T., and Yokoyama, S. (2011) Crystallographic Study of a Site-Specifically Cross-Linked Protein Complex with a Genetically Incorporated Photoreactive Amino Acid Biochemistry 50, 250-257
45. Franke, R. R., Sakmar, T. P., Oprian, D. D., and Khorana, H. G. (1988) A single amino acid substitution in rhodopsin (lysine-248-leucine) prevents activation of transducin J. Biol. Chem. 263, 2119-2122
46. Pollok-Kopp, B., Schwarze, K., Baradari, V. K., and Oppermann, M. (2003) Analysis of ligand-stimulated CC chemokine receptor 5 (CCR5) phosphorylation in intact cells using phosphosite-specific antibodies J. Biol. Chem. 278, 2190-2198
47. Ray, N. and Dorns, R. W. (2006) HIV-1 coreceptors and their inhibitors Curr. Top. Microbiol. Immunol. 303, 97-120
48. Seibert, C. and Sakmar, T. P. (2004) Small-molecule antagonists of CCR5 and CXCR4: A promising new class of anti-HIV-1 drugs Curr. Pharm. Des. 10, 2041-2062
49. Webb, D. R., Handel, T. M., Kretz-Rommel, A., and Stevens, R. C. (2013) Opportunities for functional selectivity in GPCR antibodies Biochem. Pharmacol. 85, 147-152
50. Jahnichen, S., Blanchetot, C., Maussang, D., Gonzalez-Pajuelo, M., Chow, K. Y., Bosch, L., De Vrieze, S., Serruys, B., Ulrichts, H., Vandevelde, W., Saunders, M., De Haard, H. J., Schols, D., Leurs, R., Vanlandschoot, P., Verrips, T., and Smit, M. J. (2010) CXCR4 nanobodies (VHH-based single variable domains) potently inhibit chemotaxis and HIV-1 replication and mobilize stem cells Proc. Natl. Acad. Sci. U.S.A. 107, 20565-20570
51. Scolnik, P. A. (2009) mAbs: A business perspective MAbs 1, 179-184
52. Sliwkowski, M. X. and Mellman, I. (2013) Antibody Therapeutics in Cancer Science 341, 1192-1198
53. Seibert, C. and Sakmar, T. P. (2008) Toward a framework for sulfoproteomics: Synthesis and characterization of sulfotyrosine-containing peptides Biopolymers 90, 459-477
54. Cunningham, B. C. and Wells, J. A. (1989) High-resolution epitope mapping of hGH-receptor interactions by alanine-scanning mutagenesis Science 244, 1081-1085
55. Moreira, I. S., Fernandes, P. A., and Ramos, M. J. (2007) Hot spots: A review of the protein-protein interface determinant amino-acid residues Proteins: Struct., Funct., Bioinf. 68, 803-812
56. Kortemme, T. and Baker, D. (2002) A simple physical model for binding energy hot spots in protein-protein complexes Proc. Natl. Acad. Sci. U.S.A. 99, 14116-14121
57. Chabot, D. J., Zhang, P. F., Quinnan, G. V., and Broder, C. C. (1999) Mutagenesis of CXCR4 identifies important domains for human immunodeficiency virus type 1 X4 isolate envelope-mediated membrane fusion and virus entry and reveals cryptic coreceptor activity for R5 isolates J. Virol. 73, 6598-6609
58. Signoret, N., Rosenkilde, M. M., Klasse, P. J., Schwartz, T. W., Malim, M. H., Hoxie, J. A., and Marsh, M. (1998) Differential regulation of CXCR4 and CCR5 endocytosis J. Cell Sci. 111, 2819-2830
59. Signoret, N., Oldridge, J., PelchenMatthews, A., Klasse, P. J., Tran, T., Brass, L. F., Rosenkilde, M. M., Schwartz, T. W., Holmes, W., Dallas, W., Luther, M. A., Wells, T. N. C., Hoxie, J. A., and Marsh, M. (1997) Phorbol esters and SDF-1 induce rapid endocytosis and down modulation of the chemokine receptor CXCR4 J. Cell Biol. 139, 651-664
60. Zhou, N. M., Luo, Z. W., Luo, J. S., Liut, D. X., Hall, J. W., Pomerantz, R. J., and Huang, Z. W. (2001) Structural and functional characterization of human CXCR4 as a chemokine receptor and HIV-1 co-receptor by mutagenesis and molecular modeling studies J. Biol. Chem. 276, 42826-42833
61. Amara, A., LeGall, S., Schwartz, O., Salamero, J., Montes, M., Loetscher, P., Baggiolini, M., Virelizier, J. L., and ArenzanaSeisdedos, F. (1997) HIV coreceptor downregulation as antiviral principle: SDF-1α-dependent internalization of the chemokine receptor CXCR4 contributes to inhibition of HIV replication J. Exp. Med. 186, 139-146
62. Blanpain, C., Lee, B., Vakili, J., Doranz, B. J., Govaerts, C., Migeotte, I., Sharron, M., Dupriez, V., Vassart, G., Doms, R. W., and Parmentier, M. (1999) Extracellular cysteines of CCR5 are required for chemokine binding, but dispensable for HIV-1 coreceptor activity J. Biol. Chem. 274, 18902-18908
63. Lee, B., Sharron, M., Blanpain, C., Doranz, B. J., Vakili, J., Setoh, P., Berg, E., Liu, G., Guy, H. R., Durell, S. R., Parmentier, M., Chang, C. N., Price, K., Tsang, M., and Doms, R. W. (1999) Epitope mapping of CCR5 reveals multiple conformational states and distinct but overlapping structures involved in chemokine and coreceptor function J. Biol. Chem. 274, 9617-9626
64. Bogan, A. A. and Thorn, K. S. (1998) Anatomy of hot spots in protein interfaces J. Mol. Biol. 280, 1-9
65. White, J. F., Noinaj, N., Shibata, Y., Love, J., Kloss, B., Xu, F., Gvozdenovic-Jeremic, J., Shah, P., Shiloach, J., Tate, C. G., and Grisshammer, R. (2012) Structure of the agonist-bound neurotensin receptor Nature 490, 508-513
66. Humphrey, W., Dalke, A., and Schulten, K. (1996) VMD: Visual molecular dynamics J. Mol. Graphics Modell. 14, 33-38
67. Grunbeck, A. and Sakmar, T. P. (2013) Probing G Protein-coupled Receptor-ligand Interactions with Targeted Photoactivatable Cross-linkers Biochemistry 52, 8625-8632